Evidence map›Paper›PMID 32588349›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2022

Oral and Subcutaneous Anticancer Therapy Training Course for Non-physician Healthcare Professionals: a Survey Evaluating the Relevance of its Content and its Implications in the Practice of Cancer Care.

Evgenii Shumilov, Ursula Vehling-Kaiser, Gamze Damnali, Xenia Schulz, Ulrich Kaiser, Ulrike Bacher, Florian Kaiser

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Evgenii ShumilovDepartment of Hematology and Medical Oncology, University Medicine Göttingen (UMG), Robert-Koch Strasse 40, 37075, Göttingen, DE, Germany.ORCID 0000-0003-0178-1729
Ursula Vehling-KaiserDay Care Clinic for Hematology and Oncology Landshut (HOT), Landshut, Germany.
Gamze DamnaliDay Care Clinic for Hematology and Oncology Landshut (HOT), Landshut, Germany.
Xenia SchulzDepartment of Medical Statistics, University Medicine Göttingen (UMG), Göttingen, Germany.
Ulrich KaiserInternal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
Ulrike BacherUniversity Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland.
Florian KaiserDepartment of Hematology and Medical Oncology, University Medicine Göttingen (UMG), Robert-Koch Strasse 40, 37075, Göttingen, DE, Germany. florian.kaiser@med.uni-goettingen.de.
Universitätsmedizin Göttingen · DEUniversity of Applied Sciences Landshut · DEUniversity Hospital of Bern · CHUniversity Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The creation of antitumor agents with an oral or subcutaneous route of administration has had important positive implications in the development of drugs to treat cancers, but issues such as false drug intake, uncontrolled side effects, and limited supervision may jeopardize the ability of these agents to improve treatment. A potential solution is the recruitment of non-physician healthcare professionals (i.e., nurses and physician assistants) and a special training course for them that focuses on the improvement of patient compliance. We developed and implemented three special professional training modules for non-physician healthcare professionals, which focus on the pharmacological aspects and side effects of oral and subcutaneous antitumor medications in regard to management strategies and communication issues that these non-physician healthcare professionals should address. Subsequently, we administered a questionnaire survey evaluating the course content and the implementation of the course in practice to the training participants to collect data for its implementation. Of 165 questionnaires that were administered, 44 (27%) were answered. The participants rated the course as being highly useful for their daily work. The participants reported a significant improvement in their professional expertise from the course. They emphasized the importance of medical topics and practical content to be included in the course delivery. The course encouraged 75% of the responders to start independent consultations with cancer patients that focused on questions of medication adherence for oral and subcutaneous antitumor medications, as well as the management of their side effects. Based on our results, at least a portion of the non-physician healthcare workforce is highly interested in engaging in active and autonomous co-supervision of patients who are treated with oral and subcutaneous antitumor medications. In addition to the theoretical basics of the treatment modalities, educational courses on oral and subcutaneous antitumor medications for non-physician healthcare professionals should focus on practical training and topics relevant to patient care.

Indexed as

Health PersonnelNeoplasmsDelivery of Health CareHumansReferral and ConsultationSurveys and QuestionnairesCancer patientsNon-physician healthcare professionalsOral and subcutaneous antitumor medicationsTraining course

Identifiers

PMID32588349
OpenAlexW3037763569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.